Products
We currently have eight FDA-approved products for various conditions.
| Product | Information | |
|---|---|---|
| Cambia® (diclofenac potassium) for Oral solution* |
Visit the product website for Important Safety Information, including Boxed Warning, and read the full Prescribing Information. | |
| INDOCIN® Oral Suspension | Read the Prescribing Information for Important Safety Information, including Boxed Warning. | |
| INDOCIN® (indomethacin) Suppositories | Read the Prescribing Information for Important Safety Information, including Boxed Warning. | |
| Otrexup® (methotrexate) injection for subcutaneous use | Visit the product website for Important Safety Information, including Boxed Warning, and read the full Prescribing Information (PDF). | |
| ROLVEDON® (eflapegrastim-xnst) injection, for subcutaneous use | Visit the product website for Important Safety Information, and read the full Prescribing Information. | |
| SPRIX® (ketorolac tromethamine) Nasal Spray | Visit the product website for Important Safety Information, including Boxed Warning, and read the full Prescribing Information. | |
| SYMPAZAN® (clobazam) oral film | Visit the product website for Important Safety Information, including Boxed Warning, and read the full Prescribing Information (PDF). | |
| ZIPSOR® (diclofenac potassium) Liquid filled capsules |
Visit the product website for Important Safety Information, including Boxed Warning, and download the full Prescribing Information (PDF). | |
MedWatch
To report SUSPECTED ADVERSE REACTIONS, contact Assertio Holdings, Inc. at 866-458-6389 or FDA at 1-800-FDA-1088 or www.fda.gov/safety/medwatch.
MEDICAL INFORMATION
To answer patient or healthcare provider questions regarding Assertio products including Customer Service, Product Information or Adverse Event Reporting, contact us at 800-518-1084 or medinfo@assertiotx.com.